Abstract
Purpose
To study the clinical features and long-term clinical outcomes in polypoidal choroidal vasculopathy (PCV) in eyes with different sub-foveal choroidal thickness (SFCT).
Methods
In this retrospective, observational comparative study, treatment-naïve eyes diagnosed with PCV using the ‘EVEREST-2’ study criteria were included. The eyes were divided into three groups of thin, medium and thick choroids, based on the SFCT data of total study eyes. Demographic, clinical, imaging features and treatment outcomes between the 3 groups were compared.
Results
Sixty-three eyes in 63 patients were included. Right eye was involved in 39 (61%) cases and left eye in 24 (39%) cases. Mean age was 68.3 ± 6.82 years (range 54–85 years). Mean SFCT was 274 µm (median = 269 µm), and one standard deviation was 79.2 µm. Totally, 11, 43 and 9 eyes were included in the thin, medium and thick choroid groups, respectively. The mean SFCT was 161 ± 24.1 µm, 275 ± 39.6 µm and 412 ± 26.2 µm in the thin, medium and thick choroid groups, respectively. There was no statistically significant difference in the clinical and imaging features and treatment outcomes between eyes with thin, medium and thick SFCT.
Conclusion
Eyes with PCV can have a choroid of varying thicknesses. Clinical, imaging and treatment responses were similar between the three sub-foveal choroidal thickness groups in this study. In future, more studies are required to evaluate the role of the choroidal thickness and its relationship to treatment in PCV.
Similar content being viewed by others
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Cheung CMG, Lee WK, Koizumi H et al (2019) Pachychoroid disease. Eye (Lond) 33:14–33. https://doi.org/10.1038/s41433-018-0158-4
Lee WK, Baek J, Dansingani KK et al (2016) Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness. Retina (Philadelphia, Pa) 36(Suppl 1):S73–S82. https://doi.org/10.1097/IAE.0000000000001346
Ciardella AP, Donsoff IM, Huang SJ et al (2004) Polypoidal choroidal vasculopathy. Surv Ophthalmol 49:25–37. https://doi.org/10.1016/j.survophthal.2003.10.007
Coscas G, Yamashiro K, Coscas F et al (2014) Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging. Am J Ophthalmol 158:309–318.e2. https://doi.org/10.1016/j.ajo.2014.05.004
Yang LH, Jonas JB, Wei WB (2013) Optical coherence tomographic enhanced depth imaging of polypoidal choroidal vasculopathy. Retina (Philadelphia, Pa) 33:1584–1589. https://doi.org/10.1097/IAE.0b013e318285cbb3
Nakai S, Honda S, Miki A et al (2017) Comparison of the 12-month outcomes of intravitreal ranibizumab between two angiographic subtypes of polypoidal choroidal vasculopathy. Ophthalmologica 237:123–127. https://doi.org/10.1159/000455273
Tan CSH, Ngo WK, Lim LW, Lim TH (2014) A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 98:1528–1533. https://doi.org/10.1136/bjophthalmol-2014-305059
Chaikitmongkol V, Kong J, Khunsongkiet P et al (2019) Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy. JAMA Ophthalmol 137:661–667. https://doi.org/10.1001/jamaophthalmol.2019.0565
Huang C-H, Yeh P-T, Hsieh Y-T et al (2019) Characterizing branching vascular network morphology in polypoidal choroidal vasculopathy by optical coherence tomography angiography. Sci Rep 9:595. https://doi.org/10.1038/s41598-018-37384-y
Chung SE, Kang SW, Lee JH, Kim YT (2011) Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 118:840–845. https://doi.org/10.1016/j.ophtha.2010.09.012
Takahashi Y, Koizumi H, Hasegawa T et al (2018) Comparison of subfoveal choroidal structures in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Jpn J Ophthalmol 62:576–583. https://doi.org/10.1007/s10384-018-0615-4
Kong M, Kim SM, Ham D-I (2017) Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy. PLoS ONE 12:e0184058. https://doi.org/10.1371/journal.pone.0184058
Chang Y-C, Cheng C-K (2019) Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina (Philadelphia, Pa). https://doi.org/10.1097/IAE.0000000000002583
Rayess N, Rahimy E, Ying G-S et al (2015) Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am J Ophthalmol 159(85–91):e1–e3. https://doi.org/10.1016/j.ajo.2014.09.033
Shin JY, Kwon KY, Byeon SH (2015) Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration. Acta Ophthalmol 93:524–532. https://doi.org/10.1111/aos.12653
Ho CPS, Lai TYY (2018) Current management strategy of polypoidal choroidal vasculopathy. Indian J Ophthalmol 66:1727–1735. https://doi.org/10.4103/ijo.IJO_975_18
Fenner BJ, Ting DSW, Tan ACS et al (2019) Real-world treatment outcomes of age-related macular degeneration and polypoidal choroidal vasculopathy in asians. Ophthalmol Retina. https://doi.org/10.1016/j.oret.2019.10.019
Yang J, Yuan M, Xia S, Chen Y (2019) Six-year real-world outcomes of antivascular endothelial growth factor monotherapy and combination therapy for various subtypes of polypoidal choroidal vasculopathy. J Ophthalmol 2019:1609717. https://doi.org/10.1155/2019/1609717
Uyama M, Wada M, Nagai Y et al (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133:639–648. https://doi.org/10.1016/s0002-9394(02)01404-6
Tan CS, Ngo WK, Chen JP et al (2015) EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol 99:624–628. https://doi.org/10.1136/bjophthalmol-2014-305674
Wakatsuki Y, Shinojima A, Kawamura A, Yuzawa M (2015) Correlation of aging and segmental choroidal thickness measurement using swept source optical coherence tomography in healthy eyes. PLoS ONE 10:e0144156. https://doi.org/10.1371/journal.pone.0144156
Dansingani KK, Balaratnasingam C, Klufas MA et al (2015) Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 160:1243–1254.e2. https://doi.org/10.1016/j.ajo.2015.08.028
Acknowledgements
We would like to thank our technicians, Mr. Abhishek Bhatt, Mr. Deekshit, Mr. Manjunath and Mr. Madhu for their contribution in acquiring the images and providing them to us for analysis in this study.
Funding
None.
Author information
Authors and Affiliations
Contributions
RV, SGK helped in conceptualizing the study, data acquisition, analyzing the data, interpreting the findings, writing and reviewing the manuscript. NKY helped in reviewing the manuscript. SS, AKI, VS, BVH, NJ helped in data acquisition. AP contributed to data analysis, interpreting the results and reviewing the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights
This article does not contain any studies with animals performed by any of the authors.
Consent for publication
Informed consent was obtained from all individual participants included in the study. The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his/her images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Ethical approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Narayana Nethralaya institutional review board—C-2019-05-006) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Venkatesh, R., Gadde, S.G.K., Pereira, A. et al. Impact of sub-foveal choroidal thickness on clinical features and long-term clinical outcomes in polypoidal choroidal vasculopathy. Int Ophthalmol 41, 87–97 (2021). https://doi.org/10.1007/s10792-020-01555-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-020-01555-6